Linguagen Corp., a taste technology company, announced it has received a letter from the U.S. Food and Drug Administration (FDA) indicating the agency does not have any questions regarding the GRAS (generally recognized as safe) status of its bitter blocker adenosine monophosphate (AMP).
GRAS status may be based either on a history of safe use in food prior to 1958 or on scientific procedures, which require the same quantity and quality of evidence as would be required to obtain a food additive regulation. These standards have been developed by the FDA to assure consumers they are purchasing and consuming a safe product for themselves and their families.